Financhill
Sell
24

BTAI Quote, Financials, Valuation and Earnings

Last price:
$1.78
Seasonality move :
4.9%
Day range:
$1.64 - $1.83
52-week range:
$1.29 - $49.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.02x
P/B ratio:
--
Volume:
77.7K
Avg. volume:
5.8M
1-year change:
-95.95%
Market cap:
$9.9M
Revenue:
$2.3M
EPS (TTM):
-$2.16

Earnings Data

Next earnings date for BTAI
May 09
2025
Most recent earnings per share
-$3.57
Beat by $1.57
(Mar 27/2025)
Consensus Estimate
-$5.14
(Mar 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BTAI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $400K -- -- -$2.16 --
05/09/2025 Q1 $350K -- -- -$3.04 --
03/27/2025 Q4 $718.3K $366K -$3.57 -$5.14 $1.57
11/14/2024 Q3 $1.3M $214K -$5.12 -$7.68 $2.56
08/06/2024 Q2 $1.1M $1.1M -$3.36 -$10.99 $7.63
05/09/2024 Q1 $632.6K $582K -$13.92 -$11.52 -$2.40
03/12/2024 Q4 $741.3K $376K -$12.16 -$12.72 $0.56
11/14/2023 Q3 $626K $341K -$27.52 -$20.00 -$7.52
08/14/2023 Q2 $466.9K $457K -$29.28 -$27.68 -$1.60
05/08/2023 Q1 $323.8K $206K -$29.44 -$25.37 -$4.07
03/09/2023 Q4 $1.1M $238K -$31.20 -$22.61 -$8.59
11/10/2022 Q3 -- $137K -$23.84 -- --
08/09/2022 Q2 -- -- -$21.60 -- --
05/09/2022 Q1 -- -- -$17.92 -- --
03/10/2022 Q4 -- -- -$14.88 -- --
11/10/2021 Q3 -- -- -$15.36 -- --
08/10/2021 Q2 -- -- -$17.76 -- --
05/10/2021 Q1 -- -- -$17.28 -- --
03/11/2021 Q4 -- -- -$13.92 -- --
11/12/2020 Q3 -- -- -$17.12 -- --
08/14/2020 Q2 -- -- -$16.96 -- --
05/12/2020 Q1 -- -- -$12.64 -- --
03/09/2020 Q4 -- -- -$7.20 -- --
11/14/2019 Q3 -- -- -$9.12 -- --
08/06/2019 Q2 -- -- -$8.64 -- --
05/07/2019 Q1 -- -- -$7.36 -- --
03/07/2019 Q4 -- -- -$7.36 -- --
11/09/2018 Q3 -- -- -$4.96 -- --
08/08/2018 Q2 -- -- -$3.04 -- --
05/14/2018 Q1 -- -- -$5.92 -- --
12/31/2017 Q4 -- -- -$2.66 -- --
09/30/2017 Q3 -- -- -$0.94 -- --
06/30/2017 Q2 -- -- -$0.58 -- --
03/31/2017 Q1 -- -- -$0.54 -- --

BioXcel Therapeutics Earnings Questions

  • How Much did BioXcel Therapeutics Generate in Revenue Last Quarter?

    BioXcel Therapeutics reported $366K worth of top line sales in its most recent quarter.

  • Did BioXcel Therapeutics Beat Earnings Last Quarter?

    BioXcel Therapeutics announced earnings per share of -$3.57 which represents a beat of analyst forecast a -$5.14 per share.

  • Is BioXcel Therapeutics Profitable?

    BioXcel Therapeutics reported -$956K that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for BioXcel Therapeutics EPS Next Year?

    BioXcel Therapeutics's earnings are forecast to decrease from -$23.51 per share to -$25.33 per share next year representing a decrease of -1.02%.

  • When is BioXcel Therapeutics's Earnings Date?

    BioXcel Therapeutics's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do Tesla Delivery Numbers Mean for Tesla Stock?
What Do Tesla Delivery Numbers Mean for Tesla Stock?

Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…

Is Chewy a Growth Stock to Buy?
Is Chewy a Growth Stock to Buy?

It might be a surprise to learn that during the…

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Stock Ideas

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
50
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
42
KMX alert for Apr 12

CarMax [KMX] is up 2.87% over the past day.

Buy
89
GDXU alert for Apr 12

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.

Sell
30
CRSP alert for Apr 12

CRISPR Therapeutics AG [CRSP] is up 14.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock